In 2017, Arlauckas et al. performed an in vivo imaging experiment by tracking fluorescently labelled anti-PD-1 mAbs, MC38 tumour cells, and tumour-associated macrophages (TAMs) injected into mice and following the interactions between those components [62]. This evidence concerns the gene PDCD1 and neoplasm.